Screener / SEC EDGAR /CIK 0000730464 /10-K filed Aug 6, 2026, compared with Aug 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer discretionary · Educational Services

Covista Inc. CVSA

Compare with peers Embed
Planned sales, announced before they happen

9 trading plans running, 15 Form 144 notices for $14.1M

10-Q, 10-K and Form 144
Plans running now 9 Mr. Robert Phelan, Mr. Stephen W. Beard, Mr. Michael Betz, Mr. Maurice Herrera, Dr. Karen Cox, Mr. Manjunath Gangadharan, Mr. Douglas Beck
Plans adopted 14 reported since May 2, 2023 Form 144 notices 15 $14.1M the sellers expected to sell

What CVSA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jun 13, 2025 to Sep 24, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Mr. Robert Phelan
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Sep 14, 2026 10-Q Oct 29, 2026
What the company wrote
On September 14, 2026, Mr. Robert Phelan, Covista’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 Plan. Mr. Phelan’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Phelan’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Phelan’s 10b5-1 Plan to occur not before December 15, 2026. Mr. Phelan’s 10b5-1 Plan expires on September 24, 2027. The 10b5-1 Plan governs Mr. Phelan’s sale of 22,000 shares of Covista common stock. After such sales, Mr. Phelan would continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Stephen W. Beard
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Sep 14, 2026 10-Q Oct 29, 2026
What the company wrote
On September 14, 2026, Mr. Stephen W. Beard, Covista’s Chairman and Chief Executive Officer, adopted a 10b5-1 Preset Diversification Program (the “New 10b5-1 Plan”). Mr. Beard’s New 10b5-1 Plan is a continuation of his current 10b5-1 Plan entered into on December 10, 2025, which expires on November 30, 2026 (the “Current Plan”). The New 10b5-1 Plan provides for the sale of Covista common stock that has not been sold under Mr. Beard’s Current Plan. Mr. Beard’s New 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Beard’s New 10b5-1 Plan are subject to the required “cooling-off” period with the estimated first sale date under Mr. Beard’s New 10b5-1 Plan to occur not before December 15, 2026, after the expiration of his Current Plan. Mr. Beard’s New 10b5-1 Plan expires on May 28, 2027. The New 10b5-1 Plan governs Mr. Beard’s sale of 112,859 shares of Covista common stock. After such sales, Mr. Beard would continue to satisfy the stock ownership requirements for our executive officers. Transactions under the New 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Michael Betz
Chief Growth and Innovation Officer and President of Walden University
Adopted 10b5-1 plan Jun 8, 2026 10-K Aug 6, 2026
What the company wrote
(b) On June 8, 2026 , Mr. Michael Betz , Covista’s Chief Growth and Innovation Officer and President of Walden University , entered in a Rule 10b5-1 Trading Arrangement (a “10b5-1 Plan”) . Mr. Betz’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Sales pursuant to the 10b5-1 Plan will begin no earlier than September 8, 2026. The 10b5-1 Plan end date is December 1, 2026 . The 10b5-1 Plan governs Mr. Betz’s sale of 12,600 shares of Covista common stock. After such sales, Mr. Betz will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law .
Mr. Maurice Herrera
former Senior Vice President and Chief Marketing Officer
Adopted 10b5-1 plan Mar 9, 2026 10-Q May 7, 2026
What the company wrote
On March 9, 2026, Mr. Maurice Herrera, Covista’s former Senior Vice President and Chief Marketing Officer, adopted a 10b5-1 Plan. Mr. Herrera’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Herrera’s 10b5-1 Plan are subject to the required “cooling-off” period with the estimated first sale date under Mr. Herrera’s 10b5-1 Plan to occur not before June 8, 2026. Mr. Herrera’s 10b5-1 Plan expires on December 31, 2026. The 10b5-1 Plan governs Mr. Herrera’s sale of 8,753 shares of Covista common stock. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144.
Dr. Karen Cox
President, Chamberlain University
Adopted 10b5-1 plan Dec 15, 2025 10-Q Jan 28, 2026
What the company wrote
On December 15, 2025, Dr. Karen Cox, President, Chamberlain University, adopted a 10b5-1 Plan. Dr. Cox’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Dr. Cox’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Dr. Cox’s 10b5-1 Plan to occur not before March 16, 2026. Dr. Cox’s 10b5-1 Plan expires on December 1, 2026. The 10b5-1 Plan governs Dr. Cox’s sale of 2,000 shares of Adtalem common stock. After such sales, Dr. Cox will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Manjunath Gangadharan
Vice President and Chief Accounting Officer
Adopted 10b5-1 plan Dec 15, 2025 10-Q Jan 28, 2026
What the company wrote
On December 15, 2025, Mr. Manjunath Gangadharan, Adtalem’s Vice President and Chief Accounting Officer, adopted a 10b5-1 Plan. Mr. Gangadharan’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Gangadharan’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Gangadharan’s 10b5-1 Plan to occur not before August 23, 2026. Mr. Gangadharan’s 10b5-1 Plan expires on December 1, 2026. The 10b5-1 Plan governs Mr. Gangadharan’s sale of any performance share units (“PSUs”) that may vest on August 23, 2026. If Mr. Gangadharan’s PSUs vest at 100%, 1,500 shares will be pursuant to his 10b5-1 Plan. After such sales, Mr. Gangadharan will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Robert Phelan
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Dec 12, 2025 10-Q Jan 28, 2026
What the company wrote
On December 12, 2025, Mr. Robert Phelan, Adtalem’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 Plan. Mr. Phelan’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Phelan’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Phelan’s 10b5-1 Plan to occur not before March 13, 2026. Mr. Phelan’s 10b5-1 Plan expires on December 1, 2026. The 10b5-1 Plan governs Mr. Phelan’s sale of 17,500 shares of Adtalem common stock. After such sales, Mr. Phelan will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Douglas Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
Adopted 10b5-1 plan Dec 11, 2025 10-Q Jan 28, 2026
What the company wrote
On December 11, 2025, Mr. Douglas Beck, Adtalem’s Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services, adopted a 10b5-1 Plan. Mr. Beck’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Beck’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Beck’s 10b5-1 Plan to occur not before March 12, 2026. Mr. Beck’s 10b5-1 Plan expires on November 30, 2026. The 10b5-1 Plan governs Mr. Beck’s sale of 19,230 shares of Adtalem common stock. After such sales, Mr. Beck will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Stephen W. Beard
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Dec 10, 2025 10-Q Jan 28, 2026
What the company wrote
On December 10, 2025, Mr. Stephen W. Beard, Adtalem’s Chairman and Chief Executive Officer, adopted a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”). Mr. Beard’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Beard’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Beard’s 10b5-1 Plan to occur not before March 16, 2026. Mr. Beard’s 10b5-1 Plan expires on November 30, 2026. The 10b5-1 Plan governs Mr. Beard’s sale of 142,860 shares of Adtalem common stock. After such sales, Mr. Beard will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Manjunath Gangadharan
Vice President and Chief Accounting Officer
Ended 10b5-1 plan Sep 10, 2025 10-Q Oct 30, 2025
What the company wrote
On September 10, 2025, Mr. Manjunath Gangadharan, Adtalem’s Vice President and Chief Accounting Officer, terminated his 10b5-1 Plan, previously adopted with respect to the sale of the Company’s common stock. Mr. Gangadharan’s 10b5-1 Plan was adopted on May 29, 2023 and had an end date of June 1, 2026. The 10b5-1 Plan provided for the sale of up to 2,222 shares of Adtalem’s common stock. As of the date of the termination, 1,911 shares of common stock had been sold under the 10b5-1 Plan’s terms .
Mr. Stephen W. Beard
Chairman and Chief Executive Officer
Ended 10b5-1 plan Sep 10, 2025 10-Q Oct 30, 2025
What the company wrote
On September 10, 2025, Mr. Stephen W. Beard, Adtalem’s Chairman and Chief Executive Officer, terminated a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”), previously adopted with respect to the sale of the Company’s common stock. Mr. Beard’s 10b5-1 Plan was adopted on June 10, 2025 and had an end date of May 29, 2026. The 10b5- 1 Plan provided for the sale of up to 108,000 shares of Adtalem’s common stock. As of the date of the termination, no shares of common stock had been sold under the 10b5-1 Plan’s terms.
Mr. Douglas Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
Adopted 10b5-1 plan Jun 13, 2025 10-K Aug 7, 2025
What the company wrote
On June 13, 2025, Mr. Douglas Beck, Adtalem’s Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services, entered in a 10b5-1 Plan. Mr. Beck’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Sales pursuant to the 10b5-1 Plan will begin no earlier than September 12, 2025. The 10b5-1 Plan end date is June 13, 2026. The 10b5-1 Plan governs Mr. Beck’s sale of 15,384 shares of Adtalem common stock. After such sales, Mr. Beck will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Douglas G. Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
Adopted 10b5-1 plan Jun 13, 2025 10-Q Oct 30, 2025
What the company wrote
On September10, 2025, Mr. Douglas G. Beck, Adtalem’s Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services, terminated his 10b5-1 Plan, previously adopted with respect to the sale of the Company’s common stock. Mr. Beck’s 10b5-1 Plan was adopted on June 13, 2025 and had an end date of June 13, 2026. The 10b5-1 Plan provided for the sale of up to 15,384 shares of Adtalem’s common stock. As of the date of the termination, no shares of common stock had been sold under the 10b5-1 Plan’s terms.
Mr. Stephen W. Beard
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Jun 10, 2025 10-K Aug 7, 2025
What the company wrote
On June 10, 2025, Mr. Stephen W. Beard, Adtalem’s Chairman and Chief Executive Officer, entered into a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”). Mr. Beard’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Beard’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Beard’s 10b5-1 Plan to occur not before September 12, 2025. The 10b5-1 Plan end date is May 29, 2026. The 10b5-1 Plan governs Mr. Beard’s sale of 108,000 shares of Adtalem common stock. After such sales, Mr. Beard will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. William Burke
member of Adtalem’s Board of Directors
Adopted 10b5-1 plan Aug 29, 2024 10-Q Oct 29, 2024
What the company wrote
On August 29, 2024, Mr. William Burke, a member of Adtalem’s Board of Directors, entered in a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”). Mr. Burke’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). The estimated selling start date under Mr. Burke’s 10b5-1 Plan is November 28, 2024. The 10b5-1 Plan end date is November 28, 2025. The 10b5-1 Plan governs Mr. Burke’s sale of 4,000 restricted stock units (“RSUs”) that have vested. The RSUs were acquired in connection with Adtalem’s Fourth Amended and Restated Incentive Plan of 2013 for employees and directors. After such sale by Mr. Burke, he will continue to satisfy the stock ownership requirements for our board members. Transactions under 10b5-1 trading plans will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.
Mr. Gangadharan
Chief Accounting Officer
Adopted 10b5-1 plan May 31, 2023 10-K Aug 10, 2023
What the company wrote
On May 31, 2023, Mr. Gangadharan, Adtalem’s Chief Accounting Officer, entered in a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”). Mr. Gangadharan’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). The estimated selling start date under Mr. Gangadharan’s 10b5-1 Plan is August 28, 2023. The 10b5-1 Plan end date is June 1, 2026. The 10b5-1 Plan governs Mr. Gangadharan’s sale of 2,222 restricted stock units (“RSUs”) that will vest over the duration of the 10b5-1 Plan. The RSUs will be acquired in connection with Adtalem’s Fourth Amended and Restated Incentive Plan of 2013 for directors, key executives, and managerial employees. A portion of the shares will be withheld by Adtalem or sold to cover withholding taxes. Transactions under Section 16 officer trading plans will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission to the extent required by law.
Show the other 8 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 9, 2026 Stephen Beard
Director
4,667 $604K
Oct 8, 2026 Stephen Beard
Director
3,639 $474K
Aug 27, 2026 MANJUNATH GANGADHARAN
Officer
1,802 $248K
Aug 11, 2026 Stephen Beard
Director
3,545 $448K
Jul 13, 2026 Stephen Beard
Director
5,291 $705K
Jul 7, 2026 ROBERT PHELAN
Officer
7,500 $972K
Jul 7, 2026 DOUGLAS BECK
Officer
9,615 $1.2M
Jun 11, 2026 Stephen Beard
Director
2,529 $334K
Jun 10, 2026 Stephen Beard
Director
2,762 $360K
May 8, 2026 Stephen Beard
Officer
15,874 $2.1M
May 8, 2026 MAURICE HERRERA
Former Officer
15,774 $2.1M
May 8, 2026 ROBERT PHELAN
Officer
10,000 $1.2M
May 8, 2026 DOUGLAS BECK
Officer
9,615 $1.1M
May 8, 2026 KAREN COX
Officer
2,000 $234K
May 8, 2026 MAURICE HERRERA
Former Officer
14,721 $1.9M
Show the other 7 notices

From the Form 144 XML filed with the SEC, since May 8, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVSA/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.